Diagnosis and management of rheumatoid arthritis. From: American Family Physician | Date: September 15, 2005| Author: Muller, Daniel; Rindfleisch, J. Adam | COPYRIGHT 2005 American Academy of Family Physicians. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Rheumatoid arthritis is a chronic inflammatory disease characterized by uncontrolled proliferation of synovial tissue and a wide array of multisystem comorbidities. Prevalence is estimated to be 0.8 percent worldwide, with women twice as likely to develop the disease as men. Untreated, 20 to 30 percent of persons with rheumatoid arthritis become permanently work-disabled within two to three years of diagnosis. Genetic and environmental factors play a role in pathogenesis. Although ...

Related newspaper, magazine, and journal articles from HighBeam Research

	Diagnosis and management of rheumatoid arthritis. American Family Physician ; Rheumatoid arthritis is a chronic inflammatory disease characterized by uncontrolled proliferation of synovial tissue and a wide array of multisystem comorbidities. Prevalence is estimated to be 0.8 percent worldwide, with women twice as likely to develop the disease as men. Untreated, 20 to 30
	Diagnosing rheumatoid arthritis: current criteria. American Family Physician ; Rheumatoid arthritis is a chronic, systemic inflammatory connective tissue disease of unknown etiology. It affects mainly synovial joints, resulting in relatively symmetric, polyarticular involvement. Arthritis may be mild and relapsing, or it may be severe and progressive, leading to joint
	Genetics of Rheumatoid Arthritis Mayo Clinic Proceedings ; Rheumatoid arthritis (RA) is a heterogeneous autoimmune disorder of unknown cause with variable clinical expression. About 70% of patients are women. Genetic factors play an important role and likely account for about 60% of disease susceptibility and expression. The association with the HLA-DRB1
	Anti-TNF therapy in early rheumatoid arthritis.(tumor necrosis factor)(Clinical report) Bandolier ; Anti-TNF therapy for rheumatoid arthritis has a proven high degree of effectiveness (Bandolier 99) in clinical trials and the real world (Bandolier 104). In the main all these patients were already using disease-modifying drugs, or had failed to improve on them. Two new studies [1,2] suggest that
	Most Sjorgen's patients negative for RA antibodies.(Musculoskeletal Disorders)(rheumatoid arthritis) Family Practice News ; Most patients with primary Sjorgen's syndrome test negative for anti-cyclic citrullinated peptide antibody and antikeratin antibodies, in contrast to patients with rheumatoid arthritis, a new study shows. However, primary Sjorgen's syndrome should not be ruled out in patients testing positive for
	Treatment of rheumatoid arthritis: Etanercept a recent advance / CE quiz: Questions for rheumatoid arthritis article Journal of the American Academy of Nurse Practitioners ; ... later in the disease course (Egsmose et al., 1995; van der Heide et al., 1996). Table 2 lists the most commonly used DMARDs. The news about DMARDs is not all good, however. In some patients, these drugs cause significant adverse effects, ranging from diarrhea ...
	Advances in the treatment of early rheumatoid arthritis.(Editorials)(Editorial) American Family Physician ; Rheumatoid arthritis is the most common reversible disability in the world, and its economic burden has been estimated to be between $3,600 and $60,300 annually per patient. (1) In this issue of AFP, Drs. Rindfleisch and Muller (2) summarize the approach to the patient with newly diagnosed
	Methotrexate in the treatment of rheumatoid arthritis. American Family Physician ; Methotrexate in the Treatment of Rheumatoid Arthritis Methotrexate is an effective agent for the treatment of rheumatoid arthritis. It is now widely prescribed for patients who have not tolerated or responded to gold compounds or penicillamine. Minor adverse reactions are common, and fatal
	Antioxidant status & lipid peroxidation in patients with rheumatoid arthritis Indian Journal of Medical Research ; Background & objectives: Rheumatoid arthritis (RA) is a debilitating, chronic multisystem disease with an unknown etiology. Recent findings indicate that increased oxidative stress and/or defective antioxidant status contribute to the etiology of RA. The present study was undertaken to examine
	Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate.(Original Article)(Clinical report) Southern Medical Journal ; Background: Sulfasalazine and tetracyclines are effective against rheumatoid arthritis (RA). Levofloxacin, the bacteriologically active isomer of ofloxacin, is used in the treatment of infections caused by periodontopathic bacteria and facultative anaerobic bacteria. The aim of this study is to

See all results.